BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 10461287)

  • 21. Factors determining long-term outcomes and survival in patients with coronary artery disease and ventricular tachyarrhythmias: a single center experience.
    De Sutter J; Kazmierczak J; Fonteyne W; Tavernier R; Jordaens LJ
    Pacing Clin Electrophysiol; 2000 Nov; 23(11 Pt 2):1947-52. PubMed ID: 11139964
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia.
    Roses-Noguer F; Jarman JW; Clague JR; Till J
    Heart Rhythm; 2014 Jan; 11(1):58-66. PubMed ID: 24120999
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcome of patients with nonischemic dilated cardiomyopathy and unexplained syncope treated with an implantable defibrillator.
    Knight BP; Goyal R; Pelosi F; Flemming M; Horwood L; Morady F; Strickberger SA
    J Am Coll Cardiol; 1999 Jun; 33(7):1964-70. PubMed ID: 10362200
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ventricular tachyarrhythmia after coronary bypass surgery: incidence and outcome.
    Sadr-Ameli MA; Alizadeh A; Ghasemi V; Heidarali M
    Asian Cardiovasc Thorac Ann; 2013 Oct; 21(5):551-7. PubMed ID: 24570557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Operation for ventricular tachyarrhythmias: refining current treatment strategies.
    Morris JJ; Rastogi A; Stanton MS; Gersh BJ; Hammill SC; Schaff HV
    Ann Thorac Surg; 1994 Nov; 58(5):1490-8. PubMed ID: 7979681
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Implantable defibrillator event rates in patients with unexplained syncope and inducible sustained ventricular tachyarrhythmias: a comparison with patients known to have sustained ventricular tachycardia.
    Andrews NP; Fogel RI; Pelargonio G; Evans JJ; Prystowsky EN
    J Am Coll Cardiol; 1999 Dec; 34(7):2023-30. PubMed ID: 10588219
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictors of device activation for ventricular arrhythmias and survival in patients with implantable pacemakers/defibrillators. CADENCE Investigators.
    Reiter MJ; Fain ES; Senelly KM; Robertson AD
    Pacing Clin Electrophysiol; 1994 Sep; 17(9):1487-98. PubMed ID: 7991419
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Smoking is associated with an increased risk of first and recurrent ventricular tachyarrhythmias in ischemic and nonischemic patients with mild heart failure: a MADIT-CRT substudy.
    Plank B; Kutyifa V; Moss AJ; Huang DT; Ruwald AC; McNitt S; Polonsky B; Zareba W; Goldenberg I; Aktas MK
    Heart Rhythm; 2014 May; 11(5):822-7. PubMed ID: 24509214
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of Chronic Total Occlusions and Coronary Revascularization on All-Cause Mortality and the Incidence of Ventricular Arrhythmias in Patients With Ischemic Cardiomyopathy.
    Raja V; Wiegn P; Obel O; Christakopoulos G; Christopoulos G; Rangan BV; Roesle M; Abdullah SM; Luna M; Addo T; Ayers C; Garcia S; de Lemos JA; Banerjee S; Brilakis ES
    Am J Cardiol; 2015 Nov; 116(9):1358-62. PubMed ID: 26341182
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term clinical outcome in patients with severe left ventricular dysfunction and an implantable cardioverter-defibrillator after ventricular tachyarrhythmias.
    Pelicano N; Oliveira M; Da Silva N; Antunes E; Santos S; Conceição JM; Roquette J; Quininha J
    Rev Port Cardiol; 2005 Apr; 24(4):487-98. PubMed ID: 15977773
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of Substrate Modification by Catheter Ablation on Implantable Cardioverter-Defibrillator Interventions in Patients With Unstable Ventricular Arrhythmias and Coronary Artery Disease: Results From the Multicenter Randomized Controlled SMS (Substrate Modification Study).
    Kuck KH; Tilz RR; Deneke T; Hoffmann BA; Ventura R; Hansen PS; Zarse M; Hohnloser SH; Kautzner J; Willems S;
    Circ Arrhythm Electrophysiol; 2017 Mar; 10(3):. PubMed ID: 28292751
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical outcome of patients with malignant ventricular tachyarrhythmias and a multiprogrammable implantable cardioverter-defibrillator implanted with or without thoracotomy: an international multicenter study. PCD Investigator Group.
    J Am Coll Cardiol; 1994 Jun; 23(7):1521-30. PubMed ID: 8195508
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Late results with concomitant coronary artery bypass grafting and ICD implantation.
    Lee JH; Konstantakos AK; Murrell HK; Biblo LA; Carlson MD; Mackall JA; Geha AS
    J Card Surg; 1996; 11(3):165-71. PubMed ID: 8889875
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Myocardial lactate extraction during programmed ventricular stimulation and its value for etiologically-related therapy of ischemic ventricular tachyarrhythmia].
    Vester EG; Perings C; Kuhls S; Ochiulet-Vester J; Strauer BE
    Z Kardiol; 1995 Jun; 84(6):443-58. PubMed ID: 7653084
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of the right ventricular lead position on clinical outcome and on the incidence of ventricular tachyarrhythmias in patients with CRT-D.
    Kutyifa V; Bloch Thomsen PE; Huang DT; Rosero S; Tompkins C; Jons C; McNitt S; Polonsky B; Shah A; Merkely B; Solomon SD; Moss AJ; Zareba W; Klein HU
    Heart Rhythm; 2013 Dec; 10(12):1770-7. PubMed ID: 23973954
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reverse remodeling and the risk of ventricular tachyarrhythmias in the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy).
    Barsheshet A; Wang PJ; Moss AJ; Solomon SD; Al-Ahmad A; McNitt S; Foster E; Huang DT; Klein HU; Zareba W; Eldar M; Goldenberg I
    J Am Coll Cardiol; 2011 Jun; 57(24):2416-23. PubMed ID: 21658562
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical experience with a new cardioverter defibrillator capable of biphasic waveform pulse and enhanced data storage: results of a prospective multicenter study. European Ventak P2 Investigator Group.
    Neuzner J
    Pacing Clin Electrophysiol; 1994 Jul; 17(7):1243-55. PubMed ID: 7937230
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of accelerated ventricular tachyarrhythmias on mortality in patients with implantable cardioverter-defibrillator therapy.
    Schukro C; Leitner L; Siebermair J; Pezawas T; Stix G; Kastner J; Schmidinger H
    Int J Cardiol; 2013 Sep; 167(6):3006-10. PubMed ID: 23017814
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of coronary revascularization on long-term clinical outcomes in patients with ischemic cardiomyopathy and recurrent ventricular arrhythmia.
    Elsokkari I; Parkash R; Gray CJ; Gardner MJ; AbdelWahab AM; Doucette S; Tang AS; Wells GA; Stevenson WG; Sapp JL
    Pacing Clin Electrophysiol; 2018 Jul; 41(7):775-779. PubMed ID: 29750365
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk stratification and clinical outcome of minimally symptomatic and asymptomatic patients with nonsustained ventricular tachycardia and coronary disease: a prospective single-center study.
    Giorgberidze I; Saksena S; Krol RB; Munsif AN; Kolettis T; Mathew P; Varanasi S; Prakash A; Delfaut P; Lewis CB
    Am J Cardiol; 1997 Sep; 80(5B):3F-9F. PubMed ID: 9291444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.